Press Releases

The Biotechnology Industry Organization (BIO) supports the bipartisan Safe and Accurate Food Labeling Act introduced today by Representatives Mike Pompeo (R-Kan.) and G. K. Butterfield (D-N.C.). 

“Biotechnology is an essential tool for farmers to have in the toolbox if we plan to feed an estimated 10 billion people by the year 2050 in an environmentally sound, sustainable, and affordable way,” said Rep. Mike Conaway (R-Texas)...

The Biotechnology Industry Organization (BIO) announces that executives from the biofuels, renewable chemical, and airline industries will discuss technology breakthroughs, business partnerships and sustainability initiatives during plenary programs...

“The Economic Contribution of University/Nonprofit Inventions in the United States: 1996- 2013,” estimates that, during this 18-year time period, academia-industry patent licensing bolstered U.S. gross industry output by up to $1.18 trillion.

The Biotechnology Industry Organization (BIO) calls upon Governor Herbert to sign important legislation that serves to update existing Utah laws governing substitution of interchangeable biologic medicines.

BIO today announced that agriculture industry expert Gene Harrington has joined the organization as Director of State Advocacy and State Government Affairs for Food and Agriculture within the Alliance Development & State Government Relations Department.

The Biotechnology Industry Organization (BIO) and the Colorado BioScience Association (CBSA) call upon Governor Hickenlooper to sign critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

Washington, D.C. (March 12, 2015) – Legendary television journalist and author Tom Brokaw will deliver a keynote address at the 2015 BIO International Convention®, June 15-18 in Philadelphia, Pennsylvania. The Keynote Luncheon will take place on Tuesday, June 16 from 12:00 – 1:30 pm EDT. The BIO International Convention regularly draws over 15,000 leaders from the biopharmaceutical industry, and offers targeted networking and business partnering opportunities and provides insights and inspiration on major trends affecting the industry.

Washington, D.C. (March 9, 2015) – Late last week, approximately one thousand individuals representing MST (Brazil’s Landless Workers Movement) invaded the operations of genetically engineered (GE) tree company Futuragene in Brazil.  

 

Washington, D.C. (March 6, 2015) – The Biotechnology Industry Organization (BIO) issued the following statement today regarding the approval by the Food and Drug Administration (FDA) of the first biosimilar product under the pathway created by the Biologics Price Competition and Innovation Act (BPCIA).

BIO supports the STRONG Patents Act of 2015 and will continue to advocate for passage of legislation to curb abusive patent practices.

The Biotechnology Industry Organization (BIO) has officially extended its deadline for the Rosalind Franklin Award for Leadership in Industrial Biotechnology.  In its second year, the BIO Rosalind Franklin Award was created to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.  The Rosalind Franklin Society will sponsor the 2015 BIO Rosalind Franklin Award which will be presented at the 2015 World Congress on Industrial Biotechnology to be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada.  

Washington, D.C. (February 25, 2015) – The Biotechnology Industry Organization (BIO) today applauds Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA SOS Act. The Act would exempt privately-paid user fees paid to the FDA from any future operation of sequestration.  

BIO began accepting nominations for its second annual Rosalind Franklin Award for Leadership in Industrial Biotechnology.  Each year, this award is given to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation.   The 2015 BIO Rosalind Franklin Award will be presented at the 2015 World Congress on Industrial Biotechnology to be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada. 

 

Winners of new contest to be announced at 2015 BIO International Convention in Philadelphia

BIO generally supports California's plan to readopt the state Low Carbon Fuel Standard, but is also concerned that certain aspects of the program are burdensome to small and new advanced biofuel producers.

The eighth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally friendlier products.  BIO will begin accepting nominations for the Award today, February 12, 2015.  The 2015 George Washington Carver Award will be presented at the 2015 World Congress on Industrial Biotechnology to be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada.  

Hedge fund manager Kyle Bass has opened a new door to abuse of the US patent system, exploiting the USPTO' s patent challenge proceeding as part of his cynical short-selling strategy. 

Report shows increase in funding for rare diseases and decrease in funding for chronic diseases

BIO is concerned that the Innovation Act as re-introduced today fails to meet that test, by undermining the ability of legitimate patent owners to commercialize their inventions and enforce their patent rights against infringers.

Bill would encourage vaccine research and benefit public health

Washington, D.C. (February 6, 2015) – The Biotechnology Industry Organization (BIO) applauds the introduction of the Vaccine Access, Certainty, and Innovation Act of 2015. Sponsored by Representatives Renee Ellmers (R-NC) and G.K. Butterfield (D-NC), the Act is expected to be an important part of the Energy & Commerce Committee’s 21st Century Cures Initiative and would modernize the discovery, development, and delivery of vaccines. 

Washington, D.C. (February 5, 2015) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the announced retirement of Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg: